Berman McAleer’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Other funds holding AZN
Berman McAleer's AZN Position: Q3 2026 in Review
Berman McAleer reduced its AstraZeneca (AZN) stake by 1.6% in Q3 2026, selling an estimated $11.8K and leaving 4,315 shares worth $697K. The position accounts for 0.08% of the portfolio, ranked #85.
Berman McAleer first reported a position in AZN in Q3 2025 and has held it in 5 quarters since. The position peaked at $854K in Q1 2026. 1,446 funds tracked by Wall St. Rank hold AZN as of Q3 2026.
- Berman McAleer held 4,315 shares of AstraZeneca worth $697K as of Q3 2026.
- Berman McAleer sold 71 AstraZeneca shares in Q3 2026, an estimated $11.8K.
- AstraZeneca made up 0.08% of Berman McAleer's portfolio in Q3 2026, its #85 holding.
- Berman McAleer first reported a position in AstraZeneca in Q3 2025 and has held it in 5 quarters since.
- Berman McAleer's AstraZeneca position peaked at $854K in Q1 2026.
- 1,446 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.
Based on Berman McAleer's 13F filing for Q3 2026, filed 16 Oct 2026.